Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7257216

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Consolidated statement of income
Statement of income
Net sales
1,133,000 JPY
72,000 JPY
Cost of sales
32,000 JPY
18,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
82,300,000 JPY
76,300,000 JPY
Depreciation
JPY
48,000 JPY
Operating expenses
Selling, general and administrative expenses
1,162,019,000 JPY
1,155,133,000 JPY
Operating expenses
Operating profit (loss)
-1,160,918,000 JPY
-1,155,078,000 JPY
Gross profit (loss)
1,101,000 JPY
54,000 JPY
Ordinary profit (loss)
-1,147,879,000 JPY
-1,158,929,000 JPY
Net sales
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
888,064,000 JPY
775,556,000 JPY
Non-operating income
Interest income
69,000 JPY
12,000 JPY
Other
4,000 JPY
286,000 JPY
Non-operating income
17,428,000 JPY
299,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Other
90,000 JPY
90,000 JPY
Non-operating expenses
4,388,000 JPY
4,149,000 JPY
Share issuance costs
4,298,000 JPY
1,399,000 JPY
Extraordinary losses
1,370,000 JPY
7,252,000 JPY
Impairment losses
1,369,000 JPY
7,252,000 JPY
Other
0 JPY
0 JPY
Gross profit
Profit (loss) before income taxes
-1,149,249,000 JPY
-1,166,182,000 JPY
Income taxes - current
1,900,000 JPY
1,900,000 JPY
Extraordinary losses
Income taxes
1,900,000 JPY
1,900,000 JPY
Profit (loss)
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,151,149,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY
-1,168,082,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.